Bicalutamide
Overview
Bicalutamide is a non-steroidal antiandrogen medication used primarily to treat prostate cancer. It works by inhibiting the action of male hormones in the prostate, slowing the growth of prostate cancer cells.
API suppliers (2)
Suppliers of Bicalutamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 2 hold a GMP certificate on record in the EU or UK registers · 2 hold a European CEP for this substance
- Fresenius Kabi AGGermanyCEP GMP on record
- Cipla LimitedIndiaCEP GMP on record
EU CEP holders (5)
Companies holding a valid EU Certificate of Suitability (CEP) for Bicalutamide, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Bicalutamide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.